White-coat hypertension in pregnant women
https://doi.org/10.21886/2712-8156-2022-3-4-25-31
Abstract
Hypertensive disorders during pregnancy remain a global medical and social problem, complicating 2–8% of pregnancies and associated with high maternal and perinatal morbidity and mortality. The traditional measurement of blood pressure in clinical practice is the most commonly used procedure for the diagnosis and control of the treatment of hypertension, but it is subject to significant inaccuracies caused, on the one hand, by the inherent variability of blood pressure itself (BP), and on the other hand, by errors arising from measurement methods and conditions. A high BP detected in the clinic should be confirmed by out-of-office BP measurement, 24-hour ambulatory BP monitoring, or home BP monitoring, which distinguishes chronic hypertension from white coat hypertension, in which blood pressure is elevated in the clinic, but remains normal at home, which is important to prevent excessive treatment and diagnosis of masked hypertension. White-coat hypertension is not a benign condition in which higher risks of developing preeclampsia, premature birth and small-for-gestational-age infants have been shown. In this regard, it is extremely important for clinicians to be aware of the risk factors and outcomes associated with white coat hypertension. Pregnant women should be medically monitored both during pregnancy and after delivery to detect target organ damage, cardiovascular risk factors and metabolic syndrome.
About the Authors
V. S. Chulkov
South-Ural State Medical University
Russian Federation
Russian Federation
Vasilii S. Chulkov, Dr. Sc. (Med), Professor of the Department of Faculty Therapy
Chelyabinsk
E. S. Nikolenko
South-Ural State Medical University
Russian Federation
Russian Federation
Ekaterina S. Nikolenko, resident of the 2nd year of study of the Department of Faculty Therapy
Chelyabinsk
Vl. S. Chulkov
South-Ural State Medical University
Russian Federation
Russian Federation
Vladislas S. Chulkov, Cand. Sc. (Med), Associate professor of the Department of Faculty Therapy
Chelyabinsk
References
1. Стрюк Р.И., Бунин Ю.А., Гурьева В.М., Иртюга О.Б., Коков Л.С., Коломацкая О.Е., и др. Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018. Национальные рекомендации. Российский кардиологический журнал. 2018;23(3):91-134. doi: 10.15829/1560-4071-2018-3-91-134
2. Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148-169. doi: 10.1016/j.preghy.2021.09.0
3. Чулков В.С., Мартынов А.И., Кокорин В.А. Артериальная гипертензия у беременных: дискуссионные вопросы национальных и международных рекомендаций. Российский кардиологический журнал. 2020;25(S4):46-54. doi: 10.15829/1560-4071-2020-4181
4. Sipahioglu NT, Sipahioglu F. Closer look at white-coat hypertension. World J Methodol. 2014;4(3):144-50. doi: 10.5662/wjm.v4.i3.144
5. Roberts JM, Countouris M. White Coat Hypertension in Pregnancy: The Challenge of Combining Inconsistent Data. Hypertension. 2020;76(1):35-37. doi: 10.1161/HYPERTENSIONAHA.120.15056
6. Ishikuro M, Obara T, Metoki H, Ohkubo T, Yamamoto M, Akutsu K, et al. Blood pressure measured in the clinic and at home during pregnancy among nulliparous and multiparous women: the BOSHI study. Am J Hypertens. 2013;26(1):141-8. doi: 10.1093/ajh/hps002
7. Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45(8):1298-1309. doi: 10.1038/s41440-022-00965-6.
8. Magee L, von Dadelszen P, Stones W, Mathai M. The FIGO textbook of pregnancy hypertension. London: The Global Library of Women’s Medicine; 2016.
9. Antza C, Cifkova R, Kotsis V. Hypertensive complications of pregnancy: A clinical overview. Metabolism. 2018;86:102-111. doi: 10.1016/j.metabol.2017.11.011
10. Vestgaard M, Ásbjörnsdóttir B, Ringholm L, Andersen LLT, Jensen DM, Damm P, et al. White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes. Diabetologia. 2019;62(12):2188-2199. doi: 10.1007/s00125-019-05002-9.
11. de la Sierra A, Vinyoles E, Banegas JR, Segura J, Gorostidi M, de la Cruz JJ, et al. Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients. J Hypertens. 2017;35(12):2388-2394. doi: 10.1097/HJH.0000000000001493
12. Braunthal S, Brateanu A. Hypertension in pregnancy: Pathophysiology and treatment. SAGE Open Med. 2019;7:2050312119843700. doi: 10.1177/2050312119843700
13. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation. 2002;106(1):63-8. doi: 10.1161/01.cir.0000019737.87850.5a
14. Sung SH, Cheng HM, Wang KL, Yu WC, Chuang SY, Ting CT, et al. White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension. 2013;61(6):1346-53. doi: 10.1161/HYPERTENSIONAHA.111.00569
15. Karter Y, Curgunlu A, Altinişik S, Ertürk N, Vehid S, Mihmanli I, et al. Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Press. 2003;12(5-6):307-13. doi: 10.1080/08037050310021406
16. Rath W, Tsikouras P, Schlembach D. Ambulante und häusliche Blutdruckmessung bei hypertensiven Schwangeren [Ambulatory and Home Blood Pressure Measurement in Hypertensive Pregnant Women]. Z Geburtshilfe Neonatol. 2020;224(6):333-338. (In German). doi: 10.1055/a-1266-7401
17. Lima JMO, Lobo RU, Rodrigues DHDS, Viana AB Jr, Silva RP. What happened after birth to pregnant women undergoing ambulatory blood pressure monitoring (ABPM) for the diagnosis of hypertension? J Hum Hypertens. 2020;34(12):814-817. doi: 10.1038/s41371-020-00418-y
18. Ditisheim A, Wuerzner G, Ponte B, Vial Y, Irion O, Burnier M, et al. Prevalence of Hypertensive Phenotypes After Preeclampsia: A Prospective Cohort Study. Hypertension. 2018;71(1):103-109. doi: 10.1161/HYPERTENSIONAHA.117.09799
19. Johnson S, Liu B, Kalafat E, Thilaganathan B, Khalil A. Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy: A Systematic Review and Meta-Analysis. Hypertension. 2020;76(1):157-166. doi: 10.1161/HYPERTENSIONAHA.119.14627
20. Ohkuchi A, Hirashima C, Arai R, Takahashi K, Suzuki H, Ogoyama M, et al. Temporary hypertension and white coat hypertension in the first trimester as risk factors for preeclampsia. Hypertens Res. 2019;42(12):2002-2012. doi: 10.1038/s41440-019-0307-6
21. Duffy J, Cairns AE, Richards-Doran D, van 't Hooft J, Gale C, Brown M, et al. A core outcome set for pre-eclampsia research: an international consensus development study. BJOG. 2020;127(12):1516-1526. doi: 10.1111/1471-0528.16319
22. Duffy JMN, Cairns AE, Magee LA, von Dadelszen P, van 't Hooft J, Gale C, et al. Standardising definitions for the preeclampsia core outcome set: A consensus development study. Pregnancy Hypertens. 2020;21:208-217. doi: 10.1016/j.preghy.2020.06.005
23. Синицын С.П., Чулков В.С., Вереина Н.К. Артериальная гипертензия у беременных с факторами тромбогенного риска: особенности течения различных клинических форм, состояние органов-мишеней и показатели гемостаза. Артериальная гипертензия. 2009;15(5):580-584. eLIBRARY ID: 23659364
24. Богданов С.В., Волкова Э.Г., Вереина Н.К., Жаворонкова Е.Ю., Коваленко Д.Б., Левашов С.Ю., и др. Артериальная гипертензия у беременных. Терапевтические аспекты проблемы. Челябинск: Челябинская государственная медицинская академия. 2010.
25. Брыткова Я.В., Стрюк Р.И. Особенности течения беременности у женщин с артериальной гипертонией. Кардиология. 2017;57(1):65-70. doi: 10.18565/cardio.2017.1.65-70.
26. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat hypertension during pregnancy. BJOG. 2005;112(5):601-6. doi: 10.1111/j.1471-0528.2004.00516.x
27. Furuta M, Sandall J, Cooper D, Bick D. The relationship between severe maternal morbidity and psychological health symptoms at 6-8 weeks postpartum: a prospective cohort study in one English maternity unit. BMC Pregnancy Childbirth. 2014;14:133. doi: 10.1186/1471-2393-14-133
28. Mancia G, Facchetti R, Vanoli J, Dell'Oro R, Seravalle G, Grassi G. White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage. Hypertension. 2022;79(5):1057-1066. doi: 10.1161/HYPERTENSIONAHA.121.18792. Erratum in: Hypertension. 2022;79(11):e143. PMID: 35191312.
29. Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. Heart. 2019;105(16):1273-1278. doi: 10.1136/heartjnl-2018-313453
30. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Grassi G, et al. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens. 2009;27(8):1672-8. doi: 10.1097/HJH.0b013e32832be5f9
31. Mancia G, Facchetti R, Grassi G, Bombelli M. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension. Hypertension. 2015;66(2):437-44. doi: 10.1161/HYPERTENSIONAHA.115.05367
32. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens. 2015;33(1):24-32. doi: 10.1097/HJH.0000000000000416
33. Grassi G. White-coat hypertension: not so innocent. E-Journal of Cardiology Practice. 2016;14(26).
34. Grover S, Brandt JS, Reddy UM, Ananth CV. Chronic hypertension, perinatal mortality and the impact of preterm delivery: a population-based study. BJOG. 2022;129(4):572-579. doi: 10.1111/1471-0528.16932
35. Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73(5):e35-e66. doi: 10.1161/HYP.0000000000000087
36. Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers EAP, Roeters van Lennep JE. Blood Pressure Profile 1 Year After Severe Preeclampsia. Hypertension. 2018;71(3):491-498. doi: 10.1161/HYPERTENSIONAHA.117.10338
37. Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, et al. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2015;31(5):549-68. doi: 10.1016/j.cjca.2015.02.016
38. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621. doi: 10.1136/bmj.d3621
39. Vestgaard M, Carstens Søholm J, Kjærhus Nørgaard S, Ásbjörnsdóttir B, Ringholm L, Damm P, et al. Home blood pressure in pregnancy-the upper reference limit. Blood Press Monit. 2019;24(4):191-198. doi: 10.1097/MBP.0000000000000386
40. Hoedjes M, Berks D, Vogel I, Franx A, Duvekot JJ, Steegers EA, et al. Poor health-related quality of life after severe preeclampsia. Birth. 2011;38(3):246-55. doi: 10.1111/j.1523-536X.2011.00477.x
41. Eguchi K, Ohmaru T, Ohkuchi A, Hirashima C, Takahashi K, Suzuki H, et al. Ambulatory BP monitoring and clinic BP in predicting small-for-gestational-age infants during pregnancy. J Hum Hypertens. 2016;30(1):62-7. doi: 10.1038/jhh.2015.20
42. Pierdomenico SD, Cipollone F, Lapenna D, Bucci A, Cuccurullo F, Mezzetti A. Endothelial function in sustained and white coat hypertension. Am J Hypertens. 2002;15(11):946-52. doi: 10.1016/s0895-7061(02)02993-x
43. Karter Y, Aydin S, Curgunlu A, Uzun H, Ertürk N, Vehid S, et al. Endothelium and angiogenesis in white coat hypertension. J Hum Hypertens. 2004;18(11):809-14. doi: 10.1038/sj.jhh.1001752
44. Guven A, Tolun F, Caliskan M, Ciftci O, Muderrisoglu H. Creactive protein and nitric oxide level in patients with white coat hypertension. Blood Press. 2012;21(5):281-5. doi: 10.3109/08037051.2011.649541
45. Curgunlu A, Uzun H, Bavunoğlu I, Karter Y, Genç H, Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens. 2005;19(8):629-33. doi: 10.1038/sj.jhh.1001867
46. Pierdomenico SD, Bucci A, Lapenna D, Lattanzio FM, Talone L, Cuccurullo F, et al. Circulating homocysteine levels in sustained and white coat hypertension. J Hum Hypertens. 2003;17(3):165-70. doi: 10.1038/sj.jhh.1001524
47. Martin C, Cameron J, McGrath B. Mechanical and circulating biomarkers in isolated clinic hypertension. Clin Exp Pharmacol Physiol. 2008;35(4):402-8. doi: 10.1111/j.1440-1681.2008.04886.x
48. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340
49. Ходжаева З.С., Холин А.М., Чулков В.С., Муминова К.Т. Ацетилсалициловая кислота в профилактике преэклампсии и ассоциированных акушерских и перинатальных осложнений. Акушерство и гинекология. 2018;8:12-19. doi: 10.18565/aig.2018.8.12-18
Review
For citations:
Chulkov V.S., Nikolenko E.S., Chulkov V.S. White-coat hypertension in pregnant women. South Russian Journal of Therapeutic Practice. 2022;3(4):25-31. (In Russ.) https://doi.org/10.21886/2712-8156-2022-3-4-25-31
Views:
2654
Email this article 